GENEVA, March 31 -- INCYCLIX BIO, LLC (600 Park Offices Drive, Suite 355Research Triangle Park, NC 27709) filed a patent application (PCT/US2025/046922) for "CDK2 INHIBITOR FOR THE TREATMENT OF KRAS MUTANT CANCER" on Sep 18, 2025. With publication no. WO/2026/064479, the details related to the patent application was published on Mar 26, 2026.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): TRUB, Alec, Gibson (c/o Incyclix Bio, LLC600 Park Offices Drive, Suite 355Research Triangle Park, NC 27709), ROBERTS, Patrick, Joseph (c/o Incyclix Bio, LLC600 Park Offices Drive, Suite 355Research Triangle Park...